3-Oxoacid CoA transferase 1 as a therapeutic target gene for cisplatin-resistant ovarian cancer.

about

3-Oxoacid CoA transferase 1 as a therapeutic target gene for cisplatin-resistant ovarian cancer.

Item

http://www.wikidata.org/entity/Q49777403

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@en

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@nl

type

Item

label

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@en

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@nl

prefLabel

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@en

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@nl

P1476

3-Oxoacid CoA transferase 1 as ...... atin-resistant ovarian cancer.

@en

P2093

Jong-Il Kim

http://www.w3.org/2001/XMLSchema#string

San-Duk Yang

http://www.w3.org/2001/XMLSchema#string

So Hee Ahn

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention

DNA methylation landscapes: provocative insights from epigenomics

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.

Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis.

The dynamic nature of autophagy in cancer

P304

2611-2618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7560

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434981

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5777293

http://www.w3.org/2001/XMLSchema#string